Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds

Another perk of weight-loss drugs? Fewer colon cancer deaths, a study found

A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It may boil down to inflammation. Read More

Can Antiobesity Medications Reduce the Risk for Cancer?

A meta-analysis found that antiobesity drugs — with the exception of coagonists — did not reduce the risk for overall or site-specific obesity-associated cancers. Read More

Popular weight-loss drugs could take the edge off your alcohol buzz, study finds

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ... Read More

Novo Nordisk Drug Helps Patients Lose Weight, Lower Blood Sugar in Trial

The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company. Read More

New weight loss drug, taken once weekly, leads to 20% weight loss in trial

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight. Read More

A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk

A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ... Read More